Literature DB >> 15719299

[MRI of carotid stents: influence of stent properties and sequence parameters on visualization of the carotid artery lumen].

T Straube1, S Wolf, A Flesser, M Deli, K Alfke, A Nabavi, O Jansen.   

Abstract

PURPOSE: To evaluate MR artifacts of carotid artery stents and to optimize stent properties and sequence parameters.
MATERIAL AND METHODS: Four carotid artery stents - Wallstent (mediloy), Precise (nitinol), ACCULINK (nitinol) and a stent prototype (nitinol) - were investigated in a flow model of the cervical vessels. The model was made of silicon tubing and a flow pump that produces realistic flow curves of the carotid artery. To investigate the effects of magnetic susceptibility and radiofrequency induced shielding artifacts, turbo spin echo and gradient echo sequences as well as CE-MRAs were measured. To improve the visualization of the stent lumen in a CE-MRA, flip angle as well as geometry and covering of the stent prototype were altered.
RESULTS: Susceptibility artifacts in stents of the carotid artery only influence the lumen visualization at the proximal and distal end of the braided mediloy stent. A change of stent coverings has no significant influence on radiofrequency artifacts, whereas a reduction in linking elements between stent segments and a change in diameter of stent struts improves visualization of the stent lumen. By increasing the flip angle in a CE-MRA, visualization of the stent lumen is possible in both mediloy and nitinol stents.
CONCLUSION: The choice of stent material and changes in stent geometry as well as the optimization of the flip angle of the CE-MRA may reduce susceptibility and radiofrequency artifacts, rendering feasible the CE-MRA of a stented carotid artery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15719299     DOI: 10.1055/s-2004-813878

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  6 in total

1.  Comparing different MR angiography strategies of carotid stents in a vascular flow model: toward stent-specific recommendations in MR follow-up.

Authors:  Andreas M J Frölich; Sara M Pilgram-Pastor; Marios N Psychogios; Alexander Mohr; Michael Knauth
Journal:  Neuroradiology       Date:  2010-08-19       Impact factor: 2.804

2.  Carotid artery stents: in vitro comparison of different stent designs and sizes using CT angiography and contrast-enhanced MR angiography at 1.5T and 3T.

Authors:  M Lettau; A Sauer; S Heiland; S Rohde; M Bendszus; S Hähnel
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-12       Impact factor: 3.825

3.  Off-resonance magnetic resonance angiography improves visualization of in-stent lumen in peripheral nitinol stents compared to conventional T1-weighted acquisitions: an in vitro comparison study.

Authors:  Gitsios Gitsioudis; Philipp Fortner; Matthias Stuber; Anna Missiou; Florian Andre; Oliver J Müller; Hugo A Katus; Grigorios Korosoglou
Journal:  Int J Cardiovasc Imaging       Date:  2016-08-17       Impact factor: 2.357

4.  In vitro stent lumen visualisation of various common and newly developed femoral artery stents using MR angiography at 1.5 and 3 tesla.

Authors:  R Syha; D Ketelsen; M Kaempf; S Mangold; S Sixt; T Zeller; F Springer; F Schick; C D Claussen; K Brechtel
Journal:  Eur Radiol       Date:  2012-08-17       Impact factor: 5.315

5.  In vitro comparison of different carotid artery stents: a pixel-by-pixel analysis using CT angiography and contrast-enhanced MR angiography at 1.5 and 3 T.

Authors:  Michael Lettau; Annett Sauer; Sabine Heiland; Stefan Rohde; Julia Reinhardt; Martin Bendszus; Stefan Hähnel
Journal:  Neuroradiology       Date:  2009-11-19       Impact factor: 2.804

6.  Artificial luminal narrowing on contrast-enhanced magnetic resonance angiograms on an occasion of stent-assisted coiling of intracranial aneurysm: in vitro comparison using two different stents with variable imaging parameters.

Authors:  Jee Hyun Seok; Hyun Seok Choi; So-Lyung Jung; Kook-Jin Ahn; Myeong Jin Kim; Yong Sam Shin; Bum-soo Kim
Journal:  Korean J Radiol       Date:  2012-08-28       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.